Table 1 The social, demographic and clinical characteristics of participants at baseline (n=160)
Variable | Lifestyle wellness program (n= 81) | Standard care (n= 79) | p |
|---|---|---|---|
Gender | |||
Female/Male | 31/50 | 33/46 | 0.747 |
Age | 36.2 (9.9) | 38.3 (10.7) | 0.209 |
Marital status | |||
Single/Married/Other (divorced, widow) | 64/8/9 | 62/10/7 | 0.787 |
Ethnicity | |||
Caucasian/Afro-American/other | 60/11/10 | 58/15/6 | 0.444 |
Education, years | |||
1-8/9-11/>11 years | 17/ 47/17 | 20/43/16 | 0.808 |
Occupation | |||
With/ without occupation | 36/45 | 38/40 | 0.857 |
Diagnosis (SCID) | |||
Schizophrenia/ other psychosis | 72/7 | 69/8 | 0.792 |
Age of onset, years | 23.2 (9.0) | 22.8 (8.7) | 0.805 |
Duration of illness, years | 13.1 (10.3) | 15.5 (9.9) | 0.142 |
Antipsychotic drugs | |||
First / Second generation/ Association /None | 11/57/13/0 | 7/59/11/2 | 0.382 |
Duration of current antipsychotic treatment, years | 5.1 (6.1) | 4.0 (3.6) | 0.209 |
PANSS positive | 12.3 (5.1) | 12.1 (4.5) | 0.685 |
PANSS negative | 16.7 (6.6) | 18.7 (7.3) | 0.133 |
PANSS general | 27.4 (7.0) | 30.7 (8.5 | 0.055 |
PANSS total | 56.4 (15.1) | 61.6 (17.5) | 0.138 |
Calgary | 2.6 (3.2) | 2.8 (4.7) | 0.233 |
GAF | 60.4 (15.7) | 58.9 (15.4) | 0.596 |
CGI | 3.2 (1.1) | 3.4 (1.0) | 0.571 |